Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 8:43 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–24 of 457 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: No Score Clear all

Conditions: Acne, Melasma, Rosacea, Seborrheic Dermatitis
Interventions: No Intervention; Other
Lead sponsor: Integrative Skin Science and Research; Industry
Eligibility: 18 Years and older
Enrollment: 150 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Sacramento, California

Conditions: Vestibular Migraine
Interventions: Vestibular Migraine Patient Assessment Tool and Handicap Inventory (VM-PATHI); Other
Lead sponsor: Boston Children's Hospital; Other
Eligibility: 10 Years to 20 Years
Enrollment: 70 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 3
States / cities: Needham, Massachusetts • Waltham, Massachusetts • Weymouth, Massachusetts

Conditions: Sleep, Sleep Apnea, Obesity, Mood
Interventions: Not listed
Lead sponsor: Scripps Translational Science Institute; Other
Eligibility: 18 Years and older
Enrollment: 100,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2041
U.S. locations: 1
States / cities: La Jolla, California

Conditions: Pain, Pain Control, Postoperative Pain
Interventions: Postoperative; Other
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 99 Years
Enrollment: 100 participants
Timeline: 2018
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: Cardiac Amyloidosis
Interventions: AI ECG Amyloid algorithm; Other
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 20,143 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 4
States / cities: Scottsdale, Arizona • Jacksonville, Florida • Rochester, Minnesota + 1 more

Conditions: Choroideremia
Interventions: No Intervention; Other
Lead sponsor: Biogen; Industry
Eligibility: 10 Years and older
Enrollment: 1,178 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Nausea
Interventions: Baxter Retching Faces (BARF) scale; Behavioral
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 4 Years to 12 Years
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Idiopathic Short Stature
Interventions: No treatment is given; Other
Lead sponsor: Novo Nordisk A/S; Industry
Eligibility: 3 Years to 11 Years
Enrollment: 43 participants
Timeline: 2024 – 2025
U.S. locations: 2
States / cities: Orange, California • Columbia, Maryland

Conditions: Major Adverse Cardiac Event (MACE)
Interventions: Personal Information Disclosure; Behavioral
Lead sponsor: University of Maryland, College Park; Other
Eligibility: 18 Years and older
Enrollment: 300 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025
U.S. locations: 1
States / cities: College Park, Maryland

Conditions: Chronic Pancreatitis, Chronic Pain
Interventions: Quantitative Sensory Test 1, Quantitative Sensory Test 2, Quantitative Sensory Test 3; Diagnostic Test
Lead sponsor: Anna Evans Phillips; Other
Eligibility: 18 Years and older
Enrollment: 500 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2031
U.S. locations: 2
States / cities: Baltimore, Maryland • Pittsburgh, Pennsylvania

Conditions: Advanced Solid Tumors
Interventions: mRNA-4359, Pembrolizumab, Ipilimumab, Nivolumab; Biological
Lead sponsor: ModernaTX, Inc.; Industry
Eligibility: 12 Years and older
Enrollment: 361 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2032
U.S. locations: 16
States / cities: Los Angeles, California • San Francisco, California • Aurora, Colorado + 11 more

Conditions: Pleural Mesothelioma, Non-small Cell Lung Cancer
Interventions: THOR-707, Pembrolizumab; Drug
Lead sponsor: Sanofi; Industry
Eligibility: 18 Years and older
Enrollment: 106 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 2
States / cities: Philadelphia, Pennsylvania

Conditions: Macromastia (Symptomatic)
Interventions: Pectoral II Nerve Block, Post Operative Pain Relievers; Procedure · Drug
Lead sponsor: Carilion Clinic; Other
Eligibility: 18 Years to 75 Years · Female only
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Roanoke, Virginia

Conditions: Safety and Efficacy of Sedation Medications
Interventions: Dexmedetomidine, Propofol; Drug
Lead sponsor: Boston Children's Hospital; Other
Eligibility: 3 Years to 11 Years
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2014
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Leukemia
Interventions: SCORE Intervention; Behavioral
Lead sponsor: University of Chicago; Other
Eligibility: 18 Years and older
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Emphysema, Chronic Obstructive Pulmonary Disease (COPD), Cystic Fibrosis, Pulmonary Fibrosis, Bronchiectasis, Sarcoidosis, Pulmonary Hypertension, Alpha-1 Antitrypsin Deficiency
Interventions: Transplantation of lungs obtained from Non-Heart-Beating Donors (NHBDs) after ex-vivo perfusion w/ STEEN Solution™, STEEN Solution™; Procedure · Device
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 15 Years and older
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2017
U.S. locations: 2
States / cities: Chapel Hill, North Carolina • Durham, North Carolina

Conditions: Meniscus Tear
Interventions: Reparel Sleeve, Placebo Sleeve; Device
Lead sponsor: Northwell Health; Other
Eligibility: 18 Years to 89 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2028
U.S. locations: 1
States / cities: Woodbury, New York

Conditions: Loneliness
Interventions: Self-Care Program through Heartfulness; Behavioral
Lead sponsor: Heartfulness Institute; Other
Eligibility: 14 Years to 19 Years
Enrollment: 108 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020
U.S. locations: 1
States / cities: Novi, Michigan

Conditions: Liver Diseases, Liver Fat, Diabetes Mellitus, Type 2, Non-Alcoholic Steatohepatitis
Interventions: Best Practice Alert, No Intervention; Behavioral
Lead sponsor: University of Kansas Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Kansas City, Kansas

Conditions: Ischemic Stroke
Interventions: Expiratory muscle strength training, Placebo expiratory training, Measures performed on all subjects, Pulmonary function test, Fluoroscopic swallow study; Behavioral · Drug · Radiation
Lead sponsor: University of Florida; Other
Eligibility: 50 Years to 85 Years
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2015
U.S. locations: 2
States / cities: Gainesville, Florida • Jacksonville, Florida

Conditions: Cystic Fibrosis
Interventions: Nasal endoscopy with microbiome swab and mucus collection through filter paper and sponge, Olfactory Function Testing, Survey Completion; Other
Lead sponsor: Dartmouth-Hitchcock Medical Center; Other
Eligibility: 18 Years to 99 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Lebanon, New Hampshire

Conditions: HPV, Oropharynx Cancer, HPV-Related Carcinoma, HPV-Related Malignancy, HPV Positive Oropharyngeal Squamous Cell Carcinoma
Interventions: HPV ctDNA Assay, MRI Studies, EORTC QLQ H&N 35 and C30, MDADI-HN, COST-FACIT, Intensity-Modulated Radiation Therapy (Arm A), Chemoradiation (Arm B); Diagnostic Test · Behavioral · Radiation + 1 more
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 8
States / cities: Miami, Florida • Basking Ridge, New Jersey • Middletown, New Jersey + 5 more

Conditions: Brain Concussion
Interventions: Blue Light Glasses, Computer Reading Task; Device · Other
Lead sponsor: Rochester Institute of Technology; Other
Eligibility: 18 Years to 26 Years
Enrollment: 64 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Neonatal Abstinence Syndrome, Neonatal Withdrawal Syndrome
Interventions: Buprenorphine, Morphine Sulfate; Drug
Lead sponsor: Pediatrix; Other
Eligibility: Up to 1 Year
Enrollment: 29 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2017
U.S. locations: 1
States / cities: Phoenix, Arizona

Search by objective public record fields.

The Use of Image-Based Computer Gradings in the Analysis of Acne, Rosacea, Melasma, and Seborrheic Dermatitis

Validation of the Vestibular Migraine Patient Assessment Tool and Handicap Inventory (VM-PATHI) for Adolescents

Research Framework Exploring Sleep Health

Postoperative Pain Reported to Nurses and Physicians

Artificial Intelligence Enhanced ECG to Detect Cardiac Amyloidosis

Natural Disease Progression in Participants With Choroideremia

The BARF Project: A Pilot Study Using the BARF Scale to Assess CINV in Children

A Study of the Genetic Basis of Response to Growth Hormone Treatment in Children With Idiopathic Short Stature

How Clinical and Personal Information Shape Physicians' Risk Judgments

QST Study: Predicting Treatment Response in Chronic Pancreatitis Using Quantitative Sensory Testing

Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors

A Study of SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With Lung Cancer or Mesothelioma (Pegathor Lung 202)

Pectoral Block in Breast Reduction for Pain Control

Comparing Safety and Efficacy of Dexmedetomidine and Propofol

Spiritual Care Intervention in Adult Patients Diagnosed With Acute Leukemia

Ex-vivo Perfusion and Ventilation of Lungs Recovered From Non-Heart-Beating Donors to Assess Transplant Suitability

Novel Bioactive Sleeve on Pain and PROMs

The Impact of Heartfulness Program on Loneliness in High School Students in the US

The Referral to Hepatology Can be Improved Through an Electronic Medical Record (EMR)-Based Best Practice Alert (BPA) for an Appropriate Referral

Cough and Swallow Rehab Following Stroke

Impact of Highly Effective Modulator Therapy on the Cystic Fibrosis Microbiome

A Study on Using Cell-Free Tumor DNA (ctDNA) Testing to Decide When to StartRoutine Treatment in People With Human Papilloma Virus (HPV)- Associated Oropharynx Cancer (OPC)

Effect of Blue Light Glasses on Screen Usage After a Concussion in College Students

Comparison of Buprenorphine to Morphine in Treatment of Neonatal Abstinence Syndrome (NAS)